This study is currently recruiting patients. Sponsors and Collaborators: Roswell Park Cancer Institute. Randomized phase II trial to study the effectiveness of photodynamic therapy using aminolevulinic acid in treating patients who have cutaneous T-cell lymphoma, B-cell lymphoma, or early chronic lymphocytic leukemia involving the skin.
Study ID Numbers: CDR0000269906; RPCI-DS-9732; NCT00054171
ClinicalTrials.gov Identifier: NCT00054171
COPYRIGHT 2005 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2005 Gale Group